After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Adaptimmune Therapeutics Plc ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $1.15 and fluctuated between $1.2799 as its day high and $1.1300 as its day low. The current market capitalization of Adaptimmune Therapeutics Plc ADR is $261.25M. A total of 1.15 million shares were traded on the day, compared to an average of 2.04M shares.
In the most recent transaction, Rawcliffe Adrian sold 30,080 shares of ADAP for 0.67 per share on Jan 17 ’24. After the transaction, the Chief Executive Officer now owns 44,848 company shares. In a previous transaction on Jan 17 ’24, Bertrand William C JR sold 18,908 shares at 0.67 per share. ADAP shares that Chief Operating Officer owns now total 7,785.
Among the insiders who sold shares, Norry Elliot disposed of 18,276 shares on Jan 17 ’24 at a per-share price of $0.67. This resulted in the Chief Medical Officer holding 7,785 shares of ADAP after the transaction. In another insider transaction, Lunger John sold 18,114 shares at $0.67 per share on Jan 17 ’24. Company shares held by the Chief Patient Supply Officer now total 7,785.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ADAP has a high of $2.05 and a low of $0.42.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ADAP’s latest balance sheet shows that the firm has $369.58M in Cash & Short Term Investments as of fiscal 2021. There were $25.47M in debt and $62.54M in liabilities at the time. Its Book Value Per Share was $0.17, while its Total Shareholder’s Equity was $205.96M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADAP is Buy with a score of 3.67.
